Image

The Geisel School of Medicine’s Thomas Ward and fellow researchers are “closing in on a new class of drugs that can prevent chronic migraines by interrupting the chain of events thought to create the headaches,” writes U.S. News & World Report.

“It’s very exciting, because this would be a form of prevention that might not have a lot of side effects and would be highly effective for people who have not had good treatment,“ Ward, a professor of neurology at Geisel, tells the magazine. ”The hope is these drugs will be clean, reduce the number of headaches people get, and won’t carry a lot of baggage.“

Read the full story, published 6/18/15 by U.S. News & World Report.